Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report

Epidermal growth factor receptor (EGFR) mutations are common in non-small cell lung cancers, but rare in small cell lung cancers (SCLCs). In previous reports, some SCLC patients with EGFR mutations could benefit from EGFR tyrosine kinase inhibitors (TKIs). In this study, we reported a case in which...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Wang, Lingfei, Dong, Fangyuan, Su, Jie, Du, Guanjun, Shao, Yang, Liu, Ying, He, Xuequn, Bao, Liubin, Wang, Wei, Guo, Xin, Wang, Xi
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379871/
https://ncbi.nlm.nih.gov/pubmed/32766137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01048
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares